ATOSSA THERAPEUTICS I
1,2800
27-ноября-24 16:00:04
15 мин. задержка
Акции
-0,0100
-0,78%
Сегодняшний диапазон
1,2400 - 1,3200
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
06 мар 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study
22 фев 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial
07 фев 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Issues Letter to Shareholders
09 янв 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
04 дек 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial
20 ноя 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
13 ноя 2023 09:00:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors
09 ноя 2023 09:00:00 Источник Nasdaq GlobeNewswire
-
Atossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023
18 сен 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
14 авг 2023 08:30:03 Источник Nasdaq GlobeNewswire
-
08 авг 2023 09:00:00 Источник Nasdaq GlobeNewswire
-
20 июл 2023 09:15:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
13 июл 2023 16:15:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Provides Enrollment Update for Ongoing Phase 2 Karisma-Endoxifen Clinical Trial
10 июл 2023 09:15:00 Источник Nasdaq GlobeNewswire
-
06 июл 2023 09:15:00 Источник Nasdaq GlobeNewswire
-
28 июн 2023 09:15:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces $10M Stock Repurchase Program
27 июн 2023 09:15:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Sponsorship of Are You Dense MusicFest 2023
22 июн 2023 16:15:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
21 июн 2023 10:13:54 Источник Nasdaq GlobeNewswire
-
Atossa to Participate in Fireside Chat at Healthcare Virtual Conference Presented by Maxim Group LLC
14 июн 2023 09:15:00 Источник Nasdaq GlobeNewswire